In Skin Cancer Study, Genetic Analysis Of Key Group Of Enzymes May Pave The Way For More Individualized Treatments

News — By on March 30, 2009 at 2:00 am

National Institutes of Health (NIH) researchers have identified a gene that suppresses tumor growth in melanoma, the deadliest form of skin cancer. The finding is reported in the journal Nature Genetics as part of a systematic genetic analysis of a group of enzymes implicated in skin cancer and many other types of cancer. The NIH analysis found that one-quarter of human melanoma tumors had changes, or mutations, in genes that code for matrix metalloproteinase (MMP) enzymes.

Please read the complete article and let us know what you think below.

Leave a Reply

Trackbacks

Leave a Trackback